Visual outcomes and satisfaction in patients with high myopia after cataract surgery with trifocal intraocular lens implantation

高度近视患者白内障手术联合三焦点人工晶状体植入术后的视觉效果和满意度

阅读:2

Abstract

PURPOSE: To investigate the 3-month outcomes of visual performance and satisfaction of patients with high myopia after implantation of trifocal intraocular lens (IOL). SETTING: Army Medical Center of PLA, Chongqing, China. DESIGN: Retrospective case series. METHODS: Patients were divided to 2 groups according to the spherical equivalent (SEQ) (high myopia ≤-6.0 diopters [D] and nonhigh myopia >-6.0 D). Corrected distance visual acuity (CDVA), uncorrected distance visual acuity (UDVA) at 5 m, uncorrected intermediate visual acuity (UIVA) at 60 cm, uncorrected near visual acuity (UNVA) at 40 cm, defocus curve, refraction, visual quality, and satisfaction were compared at 3 months postoperatively. RESULTS: Of 57 patients (89 eyes) enrolled, 32 eyes (36%) were highly myopic and 57 eyes (64%) were nonhighly myopic. At 3 months, both groups exhibited smooth defocus curves, with better visual acuity at 0 D, -0.5 D, and -2.0 D. Mean SEQ was -0.19 (-0.25, 0.00) D and 0.00 (-0.25, 0.00) D in the highly myopic and nonhighly myopic groups, respectively, with no significant difference ( P = .34). There were no significant differences between the 2 groups in CDVA, UDVA, UIVA, UNVA, spectacle independence, or satisfaction ( P > .05). Higher-order aberrations (HOAs) and trefoil aberration were greater in the highly myopic group ( P < .05). CONCLUSIONS: Trifocal IOL implantation provides satisfactory full-range visual acuity on the premise of no complications, with a spectacle independence rate of more than 90%. Although HOAs and trefoil aberration were greater in patients with high myopia, they achieve comparable visual acuity and spectacle independence rates, with a high satisfaction.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。